Crossmark

Humans seropositive for Trypanosoma cruzi co-infected with intestinal helminths have higher infectiousness, parasitaemia and Th2-type response in the Argentine Chaco

Crossref DOI link: https://doi.org/10.1186/s13071-024-06401-7

Published Online: 2024-08-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Enriquez, Gustavo Fabián

Macchiaverna, Natalia Paula

Garbossa, Graciela

Quebrada Palacio, Luz Piedad

Ojeda, Bárbara Leonor

Bua, Jacqueline

Gaspe, María Sol

Cimino, Rubén

Gürtler, Ricardo Esteban

Postan, Miriam

Cardinal, Marta Victoria
Funding

Funding for this research was provided by:

Agencia Nacional de Promoción Científica y Tecnológica (PICT 2018-03706, PICT 2014-2661)

Fundación Bunge y Born

Universidad de Buenos Aires (UBACYT 20020130100843BA, UBACYT 20020130100843BA)
License Information

Text and Data Mining valid from 2024-08-12

Version of Record valid from 2024-08-12
More Information

Article History

Received: 20 December 2023

Accepted: 9 July 2024

First Online: 12 August 2024

Declarations

:

: The study protocol for human serological and coprodiagnosis and etiological treatment was approved by the Comité de Ética en Investigación Clínica (CEIC) (Ethical Committee for Clinical Research), Buenos Aires, Argentina (IRB no. 00001678; Protocol no. TW–01–004).

: All authors of this manuscript have read and agreed to the content within it. Furthermore, the contents of this article are original, and we agree with the BioMed Central Copyright and License Agreement.

: Authors declare no conflicts of interest. The funding source has not been involved in study design, analysis and interpretation of data.

Document is current

Any future updates will be listed below